High levels of Nrf2 are associated with tumorigenesis and poor prognosis, and it promotes RhoA expression by interacting with and silencing the ERR1 gene, allowing breast cancer cells to proliferate and metastasize. The gene discussed is NFE2L2; the disease is breast cancer.